Non-uniform distribution of lesions and biochemical abnormalities within the retina of diabetic humans

Current Eye Research

Volumn 27, Issue 1, 2003, Pages 7-13

  Tang, J ^a,b,c   Mohr, S ^b,c   Du, Y P ^b,c   Kern, Timothy S ^b,c  

^a Heilongjian Province Hospital   (China)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Caspase; Diabetic retinopathy; Humans; Regional distribution

Indexed keywords

ARTICLE; CAPILLARY BASEMENT MEMBRANE; DIABETES MELLITUS; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERGLYCEMIA; MICROANEURYSM; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); PATHOGENESIS; PRIORITY JOURNAL; RETINA CAPILLARY; RETINA DISEASE; TISSUE DISTRIBUTION; VASCULAR DISEASE;

AGED; ANEURYSM; CADAVER; CASPASE 1; DIABETIC RETINOPATHY; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MONOSACCHARIDE TRANSPORT PROTEINS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RETINA; RETINAL VESSELS; TISSUE DISTRIBUTION;

EID: 0043207639     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.27.2.7.15455     Document Type: Article

References (35)

1. Kern TS, Engerman RL. Vascular lesions in diabetes are distributed non-uniformly within the retina. Exp. Eye Res. 1995;60:545-549.
2. Cunha-Vaz JG. Diabetic retinopathy. Human and experimental studies. Trans Ophthal Soc UK. 1972;92:111-124.
3. Shimizu K, Kobayashi Y, Muraoka K. Midperipheral fundus involvement in diabetic retinopathy. Ophthalmology. 1981;88:601-612.
4. Niki T, Muraoka K, Shimizu K. Distribution of capillary nonperfusion in early-stage diabetic retinopathy. Ophthalmol. 1984;91:1431-1439.
5. Kumagai AK, Vinores SA, Pardridge WM. Pathological upregulation of inner blood-retinal barrier GLUT-1 glucose transporter expression in diabetes mellitus. Brain Res. 1996;706:313-317.
6. Badr GA, Tang J, Ismail-Beigi F, Kern TS. Diabetes down-regulates Glut1 expression in retina and its microvessels, but not in cerebral cortex or its microvessels. Diabetes. 2000;49:1016-1021.
7. Ishii H, Takagi C, Jirousek MR et al. Normalization of retinal blood flow in diabetic rats by oral intake of an isoform-selective inhibitor of protein kinase C. Diabetes. 1995;44(Suppl):54A.
8. King GL, Kunisaki M, Nishio Y et al. Biochemical and molecular mechanisms in the development of diabetic vascular complications. Diabetes. 1996;S105-S108.
9. Kowluru RA, Jirousek MR, Stramm LE et al. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. V. Relationship between protein kinase C and ATPases. Diabetes. 1998;47:464-469.
10. Du Y, Smith MA, Miller CM, Kern TS. Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J Neurochem. 2002;80:771-779.
11. Mohr S, Tang J, Kern TS. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes. 2002;51:1172-1179.
12. de Bilbao F, Dubois-Dauphin M. Acute application of an interleukin-1 beta-converting enzyme-specific inhibitor delays axotomy-induced motoneurone death. Neuroreport. 1996;7:3051-3054.
13. Friedlander RM, Gagliardini V, Rotello RJ, Yuan J. Functional role of interleukin 1 beta (IL-1 beta) in IL-1 beta-converting enzyme-mediated apoptosis. J Exp Med. 1996;184:717-724.
14. Miura M, Zhu H, Rotello R et al. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell. 1993;75:653-660.
15. Thornberry NA, Molineaux SM. Interleukin-1 beta convening enzyme: a novel cysteine protease required for IL-1 beta production and implicated in programmed cell death. Protein Sci. 1995;4:3-12.
16. Kuwabara T, Cogan DG. Studies of retinal vascular patterns: I. Normal architecture. Arch Ophthalmol. 1960;64:904-911.
17. Engerman RL, Kern TS. Aldose reductase inhibition fails to prevent retinopathy in diabetic and galactosemic dogs. Diabetes. 1993;42:820-825.
18. Williamson JR, Vogler NJ, Kilo C. Estimation of vascular basement membrane thickness. Diabetes. 1969;18:567-578.
19. De Venecia G, Davis MD, Engerman RL. Clinicopathologic correlations in diabetic retinopathy. 1. Histology and fluorescein angiography of microaneurysms. Arch Ophthalmol. 1976;94:1766-1773.
20. Taylor E, Dobree JH. Proliferative diabetic retinopathy. Site and size of initial lesions. Brit J Ophthal. 1970;54:11-18.
21. Osterby Hansen R, Lundbaek K. The basement membrane morphology in diabetes mellitus. In: Ellenberg M, Rifkin H, eds. Diabetes Mellitus: Theory and Practice. New York: McGraw Hill; 1970:178-209.
22. Johnson PC, Brendel K, Meezan E. Thickened cerebral cortical capillary basement membranes in diabetes. Arch Pathol Lab Med. 1982;106:214-217.
23. Engerman RL, Colquhoun PJ, Jr. Epithelial and mesothelial basement membranes in diabetic patients and dogs. Diabetologia. 1982;23:521-524.
24. Sosenko JM, Miettinen OS, Williamson JR, Gabbay KH. Muscle capillary basement membrane thickness and long-term glycemia in Type 1 diabetes mellitus. N Engl J Med. 1984;311:694-698.
25. Mizutani M, Kern TS, Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J Clin Invest. 1996;97:2883-2890.
26. Barber AJ, Lieth E, Khin SA et al. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest. 1998;102:783-791.
27. Miyamoto K, Khosrof S, Bursell SE et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci USA. 1999;96:10836-10841.
28. Antonetti DA, Lieth E, Barber AJ, Gardner TW. Molecular mechanisms of vascular permeability in diabetic retinopathy. Semin Ophthalmol. 1999;14:240-248.
29. Boeri D, Maiello M, Lorenzi M. Increased prevalence of microthromboses in retinal capillaries of diabetic individuals. Diabetes. 2001;50:1432-1439.
30. Kern TS, Engerman RL. Pharmacologic inhibition of diabetic retinopathy: Aminoguanidine and aspirin. Diabetes. 2001;50:1636-1642.
31. De La Paz M, Anderson RE. Region and age-dependent variation in susceptibility of the human retina to lipid peroxidation. Invest Ophthalmol Vis Sci. 1992;33:3497-3499.
32. Berkowitz B, Frank RN, Kern TS et al. Subnormal retinal oxygenation response precedes diabetic-like retinopathy. Invest Ophthalmol Vis Sci. 1999;40:2100-2105.
33. Schwartz B, Harris A, Takamoto T et al. Regional differences in optic disc and retinal circulation. Acta Ophthalmol Scand. 2000;78:627-631.
34. Chung HS, Harris A, Halter PJ et al. Regional differences in retinal vascular reactivity. Invest Ophthalmol Vis Sci. 1999;40:2448-2453.
35. 2 predicts therapeutic efficacy in experimental diabetic retinopathy. Invest Ophthalmol Vis Sci. 2001;42:2964-2969.